Life
Briefing: Trump Administration Prepares 100% Tariffs on Some Imported Drugs
Strategic angle: The White House is readying a 100% tax on some imported medicines, a draft order shows.
editorial-staff
1 min read
Updated 9 days ago
The White House's draft order for a 100% tariff on select imported drugs signals a major shift in trade policy that could disrupt existing supply chains.
Such tariffs may lead to increased costs for pharmaceutical companies and potentially limit access to essential medications, affecting overall healthcare infrastructure.
Stakeholders in the pharmaceutical and healthcare sectors will need to assess the implications for pricing, availability, and operational logistics as this policy unfolds.